Skip to search formSkip to main contentSkip to account menu

lymphokine-activated killer cell therapy

Known as: LAK cell therapy, cell therapy, lymphokine-activated killer, therapy, lymphokine-activated killer cell 
The use of lymphokine-activated killer cells in the treatment of any disease or disorder.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The optimum incubation period, serum or plasma concentration, recombinant interleukin 2(rlL-2) concentratien, cell density and… 
2006
2006
In this study 15 consecutive melanoma patients were treated with two courses of bolus recombinant interleukin 2 (rIL2) and rIL2…